First ATMP certification opinion granted in EU
This article was originally published in RAJ Devices
Executive Summary
A somatic cell therapy for treating cardiovascular diseases has become the first product to obtain certification of experimental data by the European Medicines Agency under the European Union�s framework for advanced therapy medicinal products1,2.